Marker Therapeutics Inc (MRKR)

[ThanksforyourInsights]

As a prospective investor, the stock price performance is devastatingly clear. The valuation is basically equivalent to the money they have in the bank, though professional analysts have pegged SP higher.

A few questions to those on this board that no doubt have much better insight that me:
Without a revenue stream or a commercial release date for initial products and services, there is no way to estimate future cash requirements. Fair?
Is the published data from Baylor and MarkerT, in fact, reliable?
If the data is reliable and the underlying technology is sound, is it sufficiently differentiated from their competition [genetic engineering, 'fast' & scalable manufacturing, perhaps lower cost] to provide competitive advantage?

Appreciate your insights!